EIT Health Germany Newsletter

Subscribe, archive

The latest edition

March, 2019
View online

Dear EIT Health Partners and Friends,

At the beginning of this month's newsletter I wanted to share with you the incredibly positive results of the EIT Health Germany - Partner Satisfaction Survey 2018 & BP2019 Call Participation Analysis. We were keen to hear your views on your experience of EIT Health and the support provided by the German CLC as well as the degree of your satisfaction with the opportunities and support offered, especially our dedicated proposal support offerings during the annual EIT Health Call for Proposals. The independent, external review we commissioned was conducted in 2018 and confirmed that EIT Health's network, its European focus, its unique position in the innovation value chain and the access to funds are the main drivers for engagement in the partnership. The analysis also reiterated the great value created by the German CLC team in collaboration with the other CLC/HQ teams. To hear what past users of the German CLC's support services had to say, I'd encourage you to read the full analysis here.

As the deadline for the submission of your proposals for the EIT Health Business Plan 2020 is approaching fast (27th March 2019 by 4pm CET!) - I thought it fitting to share the above with you, and would strongly encourage you to avail yourself of our support for the current call. It's as simple as joining us in our offices in Mannheim in person during the support phase (14-27 March 2019) or alternatively joining one of our upcoming webinars / individual telephone conferences remotely. Please schedule your individual training/support session ASAP to avoid disappointment.

In other news: I highly recommend the latest edition of  "The Grand Tour: European Life Science Innovation Hubs"  - this time featuring Munich and EIT Health's role in the local ecosystem. Alternatively, if diabetes is what you're passionate about, I'd encourage you to read this excellent blogpost by Prof. Freimut Schliess: "Digital Diabetes: Better Trials, Better Drugs, Better Care".

Feel free to get in touch to join the conversation!

Dr. Katharina Ladewig

Managing Director, EIT Health Germany 


In this newsletter we bring you: 

Pillar and CLC Update

Proposal Writing Support: Important Information for Partners

Between 14th and 27th March 2019 EIT Health Germany Partners will once again be able to access our dedicated Proposal Writing Support. Participants will receive independent, impartial feedback on their (pre-)proposal, specific advice and support from external consultants to help improve their proposals, as well as PLAZA support.

Why is it important to participate in our proposal Writing sessions?
First of all, it's free for any GER CLC partner seeking assistance. Secondly, "BP newbies" benefit from the additional support in filling in the PLAZA templates. Last but not least, we have a wealth of experience and knowledge to share based on previous calls and are able to provide our partners with an EIT Health-insider perspective. 

How can partners participate?
Partners can either visit us for face2face-meetings in Mannheim or set up a telephone conference with us to work together remotely. To request a meeting please use Doodle - appointments are allocated on a first come, first serve basis, and are being snapped up fast! Thus, we encourage you to get in touch ASAP to avoid disappointment.
 

EIT Health "Start-ups meet Pharma 2019" - Last chance to apply!

Nearly 100 start-ups already applied to be part of this year's "Start-ups meet Pharma" Programme, a challenge-based-start-up support programme that connects teams of MSc, MDs, PhD students, Post-docs and professionals with key pharma partners in Europe. 



In 2019, five Challenges were released in collaboration with Amgen, Ferrer, Johnson & Johnson, and UCB Biosciences. Start-ups that are interested in participating but have no previous connection to any EIT Health partner or CLC representatives yet, may introduce themselves to our Business Creation Manager, Matteo Consonni (matteo.consonni@eithealth.eu) to discuss how to become involved.  

[Read More]


EIT Health Headstart Grant - Apply now!

The EIT Health Headstart Programme provides funding of up to €50 000 to support early-stage companies and SMEs in developing new products and services. For the 2019 challenges these should fit within the overall EIT Health objective "Healthy Living", "Active Ageing" and "Improved Healthcare"



The EIT Health Headstart Funding Programme is suitable for micro and small enterprises (according to the EU SME definition) spin-offs, and start-ups that have a well-developed prototype and are ready to launch a product. We particularly encourage start-ups and SME's that work on projects related to the EIT Health Focus Areas. The Submission deadline is 27 March 2019. Be part of this year's SHIP Event and apply here.

[Read More]

EIT Health Bootcamp Programmes

 

EIT Health' s Bootcamps are the first step towards healthy growth for start-ups and young entrepreneurs. Participants will gain the tools to validate and incubate their business idea and to build connections with the established EIT Health community of investors and mentors, helping  to get their health business off the ground and into the market. Participants will also have the chance to test their business concept with platforms including EIT Health's living labs and test beds. With access to expert mentors and training sessions, our Bootcamps are designed to take start-ups from initial ideation all the way through to launch. Check out the various programmes!

 
[Read more]

 

 

We are here to help! The EIT Health Germany Partner Satisfaction Survey


We are happy to share with you the incredibly positive results of the partner satisfaction survey commissioned by EIT Health Germany which analysed partners' overall experience of the support we offered during the BP 2019 Call for Proposals. The aim of this study was to evaluate the satisfaction level of partners with the numerous services provided by the German CLC as well as touch base with partners regarding motivation for partners to engage in the call and in EIT Health activities in general. 


[Read More]
 

The EIT Health Germany Success Story: EmergencyEye®

EmergencyEye®, developed by the EIT Health RAMSES consortium, is a software designed to allow better communication between ambulance and patients / bystanders at the scene. The innovation, which supports emergency dispatchers with speedy geolocation, diagnosis and audio-visual guidance of resuscitation measures, officially launched on the German market in late 2018. It is now being used in a number of dispatch centres across the region, e.g. in Neuss and at the main state education/training centre of the German Red Cross (DRK) in Pfalzgrafenweiler. As a result of this early roll-out stage, EmergencyEye® is already available to more than one million people and is used multiple times a day!

[Read More]
 

Follow us on Social Media...

In order to further strengthen our external communication and to spread the word more efficiently about EIT Health and its community in Germany, Switzerland and Austria we set up a dedicated EIT Health Germany LinkedIn channel and are now also part of the XING community. Please follow us and share the news!
 
                                
                              
 

Opportunities & Deadlines

Find more opportunities online


   18.03.2019 Application Deadline: Caixa Impulse,

   27.03.2019 Deadline for all challenges of "Start-ups meet Pharma"

   27.03.2019 Deadline for applications for  European Health Catapult (EHC) 2019

   27.03.2019 Deadline for all BP 2020 submissions     

   27.03.2019 Deadline Headstart Funding Programme

   31.3.2019 Application Deadline: BRAINOVATE Summer School

   

News from EIT Health Germany Partners

Researchers at FAU Erlangen receive €1.3 Mio to hunt for tiny signs of tumors in the blood and thus detect cancer earlier


If a tumor is already large enough, to be detected by medical imaging procedures, treating it - particularly aggressive cancers such as pancreatic cancer - is hardly possible. "Early detection" is therefore a mantra often repeated by oncologists. Prof. Dr. Robert Grützmann, Senior Physician of the Surgical Clinic and Director of the University Hospital Erlangen, and his team want to identify tumor markers, so that the slightest harbingers of a cancer, in the blood can be safely detect. The BMBF supports this effort with €1.3 Mio over the next three years.
[ Read More ]
 

New Fraunhofer Center for Cognitive Production Systems and AI

The Fraunhofer-Gesellschaft has launched two new research centers on cognitive systems and artificial intelligence. Both are key technologies in value creation and will play a crucial role in deciding Germany’s future viability for technological growth.
 
Visit our Website
Copyright © 2019 German EIT Health GmbH, All rights reserved.

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.